种族对常染色体显性多囊肾病移植结局的影响
该研究利用美国器官共享网络2000至2022年32,611例常染色体显性多囊肾病(ADPKD)移植受者数据,分析不同种族移植结局差异。结果显示非白人患者透析年限更长、活体及抢先移植更少,黑人患者移植肾衰竭风险显著高于白人,而亚裔和西班牙裔患者移植物存活相似但患者生存更优。
要点
- 非白人ADPKD患者活体移植和抢先移植比例更低,透析时间更长。
- 黑人患者移植肾衰竭风险显著高于白人患者。
- 亚裔和西班牙裔患者移植物存活与白人相似,但患者生存更优。
核心结论
- ADPKD患者的等待名单经历、移植物质量和移植后结局受种族影响。
- 黑人患者移植肾衰竭风险显著高于白人患者。
- 亚裔和西班牙裔患者移植物存活与白人相似但患者生存更优。
研究设计与样本
- 回顾性队列研究,使用美国器官共享网络标准移植分析与研究文件。
- 计算估计移植后生存(EPTS)评分,采用Cox模型分析移植物失败和死亡,并以竞争风险模型分析移植物失败。
主要发现
- 与白人相比,其他种族组透析年限更长、延迟移植物功能更多、活体和抢先移植更少。
- 黑人和西班牙裔患者在等待名单各时间点平均EPTS评分更低。
- 由于等待时间更长,黑人和西班牙裔患者移植时EPTS评分<20%的可能性更低。
- 黑人患者以死亡为竞争风险的移植物失败风险显著高于白人。
- 亚裔和西班牙裔患者移植物存活与白人相似,但患者生存更优。
临床怎么用
- 应关注ADPKD移植中种族差异,促进活体移植和抢先移植的公平可及。
- 对黑人ADPKD患者需加强移植后移植物失败的风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Despite overall superior outcomes, transplant outcomes of patients with autosomal dominant polycystic kidney disease are heavily influenced by race. Access to living donor and preemptive transplantation partly explains these racial disparities. Favorable Expected Post-Transplant Survival scores suggest that promoting equity would result in improved survival for patients with ADPKD. BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of ESKD and occurs without racial predilection. In general, non-White patients with ESKD have less access to transplantation, especially living donor transplantation. We examined long-term outcomes of patients with ADPKD-ESKD by self-reported race, with attention to the trajectory of Estimated Post-Transplant Survival (EPTS) scores over time. METHODS: United Network for Organ Sharing Standard Transplant Analysis and Research files were used to identify 32,611 ADPKD transplant recipients between January 2000 and December 2022. EPTS scores were calculated from the date of waitlisting until transplantation occurred. Cumulative incidences of living and deceased transplantation were calculated and plotted. Cox models were made for graft failure and death, and a subdistribution hazards model for graft failure accounted for death as a competing outcome, with adjustment for patient, donor, and transplant factors. RESULTS: Compared with White patients with ADPKD, all other groups had more dialysis years, more delayed graft function, and fewer living and preemptive transplants; mean EPTS scores were lower in Black and Hispanic patients at each time point on the waitlist. However, EPTS scores at the time of transplant was less likely to be <20% in Black and Hispanic patients because of longer waiting time. Black patients had a significantly higher risk of graft failure with death as competing risk compared with White patients. Asian and Hispanic patients had similar graft survivals but better patient survival compared with White patients. CONCLUSIONS: Waitlist experience, allograft quality, and post-transplant outcomes of patients with ADPKD are influenced by patient race.
引用
- Krishnamoorthy S, Satishchandra NG, Chapman A, et al. Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2025. PMID: 39874088. doi:10.2215/CJN.0000000626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。